Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Embolotherapy Market Forecast Highlighting Growth From $5.27 Billion To $7.33 Billion
The embolization market has experienced substantial expansion lately, projecting a rise from $4.84 billion in 2025 to $5.27 billion in 2026, reflecting a Compound Annual Growth Rate (CAGR) of 8.9%. Key factors driving this historical growth include the proliferation of interventional radiology services, a rising incidence of malignancies, innovations in catheter designs, a decrease in surgical complication risks, and the enhancement of hospital facilities.
The embolotherapy market is poised for robust expansion over the coming years, projected to reach $7.33 billion by 2030, driven by an 8.6% compound annual growth rate. This anticipated surge is underpinned by several key factors including an increasing number of oncology patients, a growing preference for treatments that preserve organs, continuous innovation in liquid embolic agents, the proliferation of ambulatory surgical centers, and enhancements in imaging and navigation technologies. During this forecast period, significant trends are expected to shape the market, such as a greater embrace of minimally invasive procedures, increased utilization of image-guided interventional therapies, escalating demand for precisely targeted cancer treatments, ongoing technological progress in embolic materials, and the broadening scope of interventional radiology services.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21181&type=smp
Embolotherapy Market Industry Drivers: What Is Driving Revenue Growth?
The growing inclination towards less invasive medical interventions is poised to fuel the expansion of the embolotherapy market in the future. These less invasive treatments, which often involve cosmetic applications, necessitate minimal surgical involvement, generally leading to shorter recovery periods and diminished risks. Factors contributing to this surge in demand for minimally invasive options include quicker recuperation, alleviated discomfort, less noticeable scarring, a decreased likelihood of adverse events, and ongoing technological innovations. Embolotherapy plays a crucial role in augmenting these minimally invasive techniques by precisely obstructing blood flow in specific blood vessels, thereby minimizing bleeding, addressing tumors, and effectively managing vascular irregularities with enhanced accuracy and fewer complications. As an illustration, the American Society of Plastic Surgeons, a U.S.-based nonprofit organization, reported in September 2023 that minimally invasive cosmetic procedures saw a 7% increase in 2023, climbing to 25,442,640 procedures from 23,672,269 in the preceding year. Consequently, the increasing adoption of minimally invasive procedures is acting as a significant catalyst for the embolotherapy market’s growth.
Embolotherapy Market Segment Analysis: What Are The Major Market Categories?
The embolotherapy market covered in this report is segmented –
1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices
2) By Application: Oncology, Peripheral Vascular Diseases, Urology And Nephrology, Neurology, Gastrointestinal (GIT) Disorders
3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)
4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users
Subsegments:
1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils
2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles
3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons
4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems
5) By Support Devices: Guidewires, Catheters, Sheath Introducers
#Embolotherapy Market Growth Trends: What Is Influencing The Future Outlook?
Key players within the embolotherapy sector are prioritizing the creation of cutting-edge solutions, notably bioabsorbable embolic systems, with the aim of improving patient recovery and broadening therapeutic possibilities. These absorbable embolic systems involve the utilization of naturally degrading materials during embolization interventions to impede blood circulation to specific areas like tumors or aneurysms, eventually dissolving within the body. A pertinent example occurred in January 2025 when Instylla Inc., a medical device manufacturer based in the United States, secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Tembo embolic system. This system, comprised of precisely sized dry-gelatin particles ranging from 85 to 255 µm and possessing irregular shapes, functions as a biodegradable agent for embolization. It is specifically engineered for the embolization of hypervascular tumors and the closure of blood vessels in the peripheral circulatory system. Instylla highlights that the Tembo system presents benefits including simplified preparation, excellent visualization, and the capacity for substantial vessel packing, thereby offering a potential enhancement over current permanent embolic devices.
Embolotherapy Market Leading Companies Driving Competitive Growth
Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation, Medtronic PLC, Johnson And Johnson, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Meril Life Sciences Pvt. Ltd., Guerbet, Cardiva, Rapid Medical, Emboline Inc, Microport Scientific, Embolx Inc, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO. LTD, Varian Medical Systems Inc.
Access The Complete Embolotherapy Market Report:
https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report
Embolotherapy Market Regional Outlook: Where Are The Largest Opportunities Located?
North Americawas the largest region in the embolotherapy market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
